![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » TARO RECEIVES NASDAQ NOTICE OF POSSIBLE DELISTING FOR DELAYED FILING OF 2005 FORM 20-F
TARO RECEIVES NASDAQ NOTICE OF POSSIBLE DELISTING FOR DELAYED FILING OF 2005 FORM 20-F
July 21, 2006
Taro Pharmaceutical Industries Ltd. reported today that on July 19, 2006 it received a Staff Determination from the Listing Qualifications Department of The Nasdaq Stock Market. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=3504459)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct